APPROPRIATE REJECTION OF INCORRECT AI ADVICE IN CLINICAL DECISION SUPPORT: A REVIEW AND SAFETY FRAMEWORK
International Journal of Advanced Research · 31.05.2026 · 14 (05) · 1170-1182
DOI: 10.21474/ijar01/23524 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Advanced Research, online erschienen am 31.05.2026. Verfasst von Albert Bacelar.
Abstract (Originalsprache)
Background: Explainable artificial intelligence is frequently presented as a route to transparent and safer clinical decision support. In high-risk decisions, increased trust is not equivalent to safer use. When artificial intelligence advice is incorrect, incomplete, or clinically under - specifi ed, a plausible explanation may convert error into an apparently acceptable recommendation. Materials and Methods: This narrative review synthesised DOI-indexed literature on clinical explainable artificial intelligence, clinical decision support, trust calibration, advice- taking, unsafe recommendat ions, false confirmation, overreliance, cognitive forcing, human-AI coll aboration, reporting standards, and health AI assurance. The analysis was organised around appropriate rejection: the clinicians capacity to reject incorrect AI advice while preserving appropriate reliance when AI advice is clinically valid.
Zitieren
APA
Bacelar, A. (2026). APPROPRIATE REJECTION OF INCORRECT AI ADVICE IN CLINICAL DECISION SUPPORT: A REVIEW AND SAFETY FRAMEWORK. International Journal of Advanced Research, 14(05), 1170-1182. https://doi.org/10.21474/ijar01/23524
Vancouver
Bacelar A. APPROPRIATE REJECTION OF INCORRECT AI ADVICE IN CLINICAL DECISION SUPPORT: A REVIEW AND SAFETY FRAMEWORK. International Journal of Advanced Research. 2026;14(05):1170-1182. doi:10.21474/ijar01/23524
BibTeX
@article{Bacelar2026,
author = {Bacelar, Albert},
title = {APPROPRIATE REJECTION OF INCORRECT AI ADVICE IN CLINICAL DECISION SUPPORT: A REVIEW AND SAFETY FRAMEWORK},
journal = {International Journal of Advanced Research},
year = {2026},
volume = {14},
number = {05},
pages = {1170--1182},
doi = {10.21474/ijar01/23524}
}
EUVIMED